GSK - a leading global healthcare and pharmaceutical research company - is committed to improving quality of life by helping men and women do more, feel better and live longer.
GSK Vaccines, one of three divisions of GSK (Vaccines, Prescription Medicines and Consumer Health Products), is one of the world's leading vaccine manufacturers, with a portfolio of more than 20 vaccines for infants, adolescents and adults as well as 18 other vaccines in development. Vaccines are produced by GSK every day and shipped to people in 158 countries. In Belgium, the more than 9,000 employees of GSK make it the largest pharmaceutical company.
Imec is a world-leading research and innovation centre in nanoelectronics and digital technologies. Imec leverages its state-of-the-art R&D infrastructure and its team of more than 5,000 employees and top researchers, for R&D in advanced semiconductor and system scaling, silicon photonics, artificial intelligence, beyond 5G communications and sensing technologies, and in application domains such as health and life sciences, mobility, industry 4.0, agrofood, smart cities, sustainable energy, education, … Imec unites world-industry leaders across the semiconductor value chain, Flanders-based and international tech, pharma, medical and ICT companies, start-ups, and academia and knowledge centres. Imec is headquartered in Leuven (Belgium), and has research sites across Belgium, in the Netherlands, Taiwan and the USA, and offices in China, India and Japan. In 2020, imec's revenue (P&L) totalled 680 million euro.
Imec is a registered trademark for the activities of imec International (IMEC International, a legal entity set up under Belgian law as a “stichting van openbaar nut”), imec Belgium (IMEC vzw supported by the Flemish Government), imec the Netherlands (Stichting IMEC Nederland), imec Taiwan (IMEC Taiwan Co.), imec China (IMEC Microelectronics (Shanghai) Co. Ltd.), imec India (IMEC India Private Limited), imec San Francisco (IMEC Inc.) and imec Florida (IMEC USA Nanoelectronics Design Center Inc.).